Template Vacancy

FUNCTIENAAM Intravacc is dé plek in Nederland met een breed toegankelijke en complete infrastructuur voor translationeel vaccinonderzoek en -ontwikkeling. Op het instituut worden goede ideeën uit de wetenschap verder geholpen op het pad naar vaccins die waardevol zijn voor zowel de volksgezondheid als het bedrijfsleven. Het instituut rekent zowel de (inter)nationale overheid als diverse farmaceutische…

Webinar ‘In search of a corona vaccine’

Intravacc Receives US NIH/NIAID Contract to Develop Enterovirus D68 Vaccine Bilthoven, The Netherlands, 8 September, 2020 – Intravacc, a global leader in translational research and development of viral and bacterial vaccines, today announced that it has been awarded a contract with base and options that may total US$9.4 million from the US National Institute of…

Intravacc Receives US NIH/NIAID Contract to Develop Enterovirus D68 Vaccine

Intravacc Receives US NIH/NIAID Contract to Develop Enterovirus D68 Vaccine Intravacc and Celonic to develop and produce a novel COVID-19 vaccine • Combining Intravacc’s OMV-delivery platform with Covid-19 Spike proteins • Preclinical studies to start shortly for candidate selection and inhouse pilot scale GMP production Strain selection and generation For development and improvement of viral…

News •

Intravacc to in-license CimCure’s iBoost technology, expanding its vaccine platform portfolio iBoost technology well suited for developing cancer vaccines Joint development of Covid-19 vaccine using iBoost

News •

Intravacc and Leiden University developed an animal replacement method for vaccines. Need for alternatives to animal testing in quality control of vaccines Inactivation of vaccines can be traced without using laboratory animals.

News •

Intravacc and Celonic to develop and produce a novel COVID-19 vaccine Combining Intravacc’s OMV-delivery platform with Covid-19 Spike proteins Preclinical studies to start shortly for candidate selection and inhouse pilot scale GMP production